BioSkryb specialises in precision single-cell genomics, leveraging its innovative Primary Template-directed Amplification (PTA) technology to deliver highly accurate, uniform DNA amplification. This enables comprehensive genomic coverage and reliable data for applications like rare variant detection, tumour profiling, and single-cell research.
